Letter to the Editor
Author's reply. “Immunogenicity, effectiveness and safety of COVID-19 vaccine in older adults living in nursing homes: Comment”
Respuesta de los autores: «Inmunogenicidad, efectividad y seguridad de la vacuna COVID-19 en adultos mayores que viven hogares geriátricos: comentario»
Héctor Meijide Mígueza, Iñaki Montes Garcíab, Miguel Ochando Gómezc, Isabel M. García Merinod, Emilio L. Canoe,f, Alejandro De La Torreg,
Corresponding author
a Department of Internal Medicine, Hospital Quironsalud A Coruña, A Coruña, Spain
b Executive Director, Residencia Dulcinea, Grupo Quirónsalud, Alcázar de San Juan, Ciudad. Real, Spain
c Technical Director of Clinical Laboratory, Health Diagnostic, Grupo Quironsalud, Madrid, Spain
d Department of Research and Innovation, Grupo Quirónsalud, Madrid, Spain
e Research Centre for Intelligent Information Technologies (CETINIA-DSLAB), Rey Juan Carlos University, Móstoles, Spain
f Quantitative Methods and Socio-economic Development Group, Institute for Regional Development (IDR), University of Castilla-La Mancha (UCLM), Albacete, Spain
g Scientific Director, Clinica Imbanaco, Grupo Quironsalud, Cali, Valle del Cauca, Colombia
Read
32
Timeswas read the article
1
Total PDF
31
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 July | 1 | 0 | 1 |
| 2024 June | 6 | 0 | 6 |
| 2024 May | 3 | 0 | 3 |
| 2024 April | 2 | 0 | 2 |
| 2024 March | 3 | 0 | 3 |
| 2024 February | 3 | 0 | 3 |
| 2024 January | 6 | 0 | 6 |
| 2023 December | 4 | 0 | 4 |
| 2023 June | 1 | 0 | 1 |
| 2023 May | 2 | 1 | 3 |
